Mofecept Film Tablet 500 Mg

Description

Mofecept stands as a film-coated tablet, each carrying 500 mg of the active ingredient, mycophenolate mofetil. It is a remarkable creation by Koçak Farma İlaç ve Kimya Sanayi A.Ş, a name synonymous with pharmaceutical excellence.

The Mechanism of Action

Mofecept’s prowess lies in its ability to inhibit an enzyme known as inosine monophosphate dehydrogenase (IMPDH). By performing this crucial function, it takes center stage in suppressing the immune system, a vital aspect of post-transplant care.

Indications

The primary mission of Mofecept is to serve as a bulwark against the rejection of transplanted organs such as the kidney, heart, or liver by the recipient’s immune system. This guardian of transplants can be administered either in conjunction with a calcineurin inhibitor or corticosteroids, the trusted allies in preventing organ rejection.

Packaging

Mofecept comes in two practical packaging options, offering 50 and 150 film-coated tablets, ensuring convenience and flexibility.

Equivalents

In the world of pharmaceuticals, alternatives often abound. Mofecept is no exception. Several equivalent medications share the same mission. Some of its counterparts include:

• CELPTU
• MICOSEF
• MIKOCEPT

Precautions

While mycophenolate mofetil in Mofecept proves invaluable in immunosuppression, it does come with certain considerations. Notably, it can reduce your body’s ability to combat infections. Vigilance is key, making sun protection paramount to avoid potential skin issues. Additionally, this medication can affect unborn babies, mandating stringent birth control measures for both men and women of childbearing age. Always consult your healthcare provider for tailored guidance before embarking on this medication.

Side Effects

As with any medication, side effects can occur. Common side effects linked to Mofecept administration include anemia, leukopenia, constipation, diarrhea, vomiting, dyspepsia, urinary tract infection, CMV infection, insomnia, and postoperative pain. It’s important to understand that this list isn’t exhaustive, and individual reactions may vary. Consulting your healthcare provider is the safest course of action.

The Right Dosage 

The recommended dosage of Mofecept hinges on factors such as age and condition:

• For adult kidney transplant patients, the advised dose is 720 mg, administered twice daily, totaling 1440 mg daily.
• Pediatric kidney transplant patients, aged 5 years and older and at least 6 months post-transplant, may receive 400 mg/m² body surface area (BSA), twice daily (up to a maximum dose of 720 mg administered twice daily).

Crucially, Mofecept tablets should be taken on an empty stomach, either one hour before or two hours after a meal.

Mofecept Half-Life

Understanding the pharmacokinetics of Mofecept is paramount. The active moiety, mycophenolic acid, boasts a mean elimination half-life ranging from 8-16 hours. In simpler terms, it takes 8-16 hours for the body’s mycophenolic acid concentration to reduce by half.

Conclusion

Mofecept Film Tablet 500 mg is a beacon of hope in the realm of immunosuppressive therapy. Its mycophenolate mofetil core is a potent guardian of transplanted organs, shielding them from rejection. However, its usage demands careful consideration and professional guidance. Your healthcare provider’s expertise is instrumental in harnessing the full potential. With precision and expert advice, this medication empowers organ transplant recipients on their journey to better health.